Crossmark

Association of baseline tumor-infiltrating lymphocytes and cell-cycle regulation markers on prognosis and mortality in patients with advanced breast cancer according to tumor characteristics and treatment type: an observational study

Crossref DOI link: https://doi.org/10.1007/s10549-026-07991-9

Published Online: 2026-06-04

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vuoti, Sauli

Saari, Minna

Lahti, Janne

Narasimha, Kumar

Reinikainen, Kai
Funding

Funding for this research was provided by:

University of Oulu
License Information

Text and Data Mining valid from 2026-06-01

Version of Record valid from 2026-06-04
More Information

Article History

Received: 4 March 2026

Accepted: 21 May 2026

First Online: 4 June 2026

Declarations

:

: All patients consented to participate in a observational IRB-approved registry protocol to collect their full health data retrospectively during the 5-year study period and biospecimens prospectively at the time of advanced breast cancer diagnosis. The specific analysis of the data in the registry for this study was further approved via a separate IRB-approved protocol.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below